Glycitein (Isoflavone · Soy Minor Isoflavone · Phytoestrogenic)

Compound	Glycitein
Chemical class	Polyphenol — Isoflavone (6-Methoxydaidzein)
CAS	40957-83-3
Primary source	Glycine max (soybean germ)
Key applications	Phytoestrogenic, antioxidant, anti-inflammatory
Claim strength	Moderate
Typical form	Soy isoflavones extract (minor co-constituent)
Buy from Herbuno	Soy Isoflavones 80% Powder (Soy Extract) | Standardized Glycine max → Soy Isoflavones 40% Powder (Soy Extract) | Standardized Glycine max →

Name origin: From Glycine max (soybean), the sole primary commercial source. Glycitein is the minor third soy isoflavone alongside genistein and daidzein, constituting approximately 5–10% of total soy isoflavone content. It is distinguished by a 6-methoxy group (on the A-ring) absent in genistein and daidzein. Traditional use: Shares the soy food and supplement traditional context. Glycitein is enriched in soy germ relative to soy cotyledon; soy germ-derived extracts have higher glycitein fractions than standard soybean preparations. Research trajectory: Glycitein is significantly underresearched compared to genistein and daidzein due to its lower abundance and later phytochemical characterisation. Recent research has highlighted potentially unique bioactivities including antioxidant activity exceeding genistein and distinct ER subtype interactions. Commercial source: Glycitein is accessible as a minor co-constituent of soy isoflavone extract (40% and 80% total isoflavones); isolated glycitein is not widely available at commercial supplement scale. See sourcing options below.

---

Evidence for Glycitein Applications

Phytoestrogenic activity: Glycitein binds ERα and ERβ with preference for ERβ, similar to daidzein but with slightly different binding kinetics attributable to the 6-methoxy group. In vitro estrogenic activity is comparable to daidzein. Clinical evidence is not available for isolated glycitein; effects are delivered within the soy isoflavone complex. Claim strength: Moderate (mechanism established; clinical data from soy complex only).

Antioxidant capacity: The 6-methoxy group on the A-ring of glycitein may increase antioxidant capacity relative to daidzein by enhancing electron-donating properties of the molecule. DPPH and ABTS assays show glycitein comparable or slightly superior to daidzein in radical scavenging. Claim strength: Moderate.

Anti-inflammatory signalling: Glycitein inhibits NF-κB and reduces COX-2 expression in macrophage models at concentrations achievable via soy isoflavone supplementation. Limited dedicated in vivo data. Claim strength: Emerging.

---

Dosage & Formulator Specification

Glycitein is not formulated as a standalone supplement ingredient. It is co-delivered via soy isoflavones extract. In a 125 mg dose of Soy Isoflavones 80% extract, glycitein content is approximately 5–12 mg depending on source and extraction method (soy germ vs cotyledon material).

For formulations seeking higher glycitein fraction, specify soy germ–derived extract. Soy germ extracts typically contain 2–3-fold higher glycitein percentage relative to total isoflavones versus standard soybean cotyledon extracts. Request an individual isoflavone profile CoA to confirm glycitein quantification.

Glycitein has similar physicochemical properties to daidzein; standard formulation approaches apply. The 6-methoxy group provides slightly higher lipophilicity than daidzein, potentially improving passive membrane permeability.

---

Frequently Asked Questions — Glycitein

Why is glycitein less studied than genistein and daidzein?
Glycitein constitutes only 5–10% of total soy isoflavone content versus genistein (~50%) and daidzein (~40%), making it less accessible for dedicated research. Its later phytochemical characterisation and lower commercial availability as an isolate have also limited research focus. Recent interest in soy germ-derived isoflavone profiles has begun to generate more glycitein-specific data.

Does glycitein convert to any active metabolite like daidzein converts to equol?
No equol-equivalent conversion pathway has been identified for glycitein. It does not appear to undergo significant gut microbial conversion to a more potent metabolite, unlike daidzein. This means glycitein’s activity is more directly dependent on absorption of the native compound rather than metabolic activation.

Is glycitein relevant as a formulation differentiator for soy isoflavone products?
It can be, particularly for brands positioning on complete soy isoflavone profiles versus isolated genistein/daidzein products. Marketing the full-spectrum nature of soy isoflavones (genistein + daidzein + glycitein) is a scientifically accurate differentiator from single-isoflavone isolate products.

Is soy germ extract preferable to standard soy extract for glycitein content?
Yes, if glycitein content is a formulation priority. Soy germ contains proportionally more glycitein than the whole bean or cotyledon fraction. Specify soy germ as the extraction source and request individual isoflavone HPLC quantification to confirm the glycitein percentage of the total isoflavone content.

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery